News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
227,369 Results
Type
Article (5253)
Company Profile (17)
Press Release (222099)
Section
Business (82623)
Career Advice (533)
Deals (15095)
Drug Delivery (8)
Drug Development (19189)
Employer Resources (41)
FDA (3700)
Job Trends (3937)
News (120810)
Policy (7576)
Tag
Academia (307)
Accelerated approval (2)
Adcomms (3)
Allergies (11)
Alliances (14890)
ALS (20)
Alzheimer's disease (248)
Antibody-drug conjugate (ADC) (11)
Approvals (3720)
Artificial intelligence (45)
Autoimmune disease (3)
Automation (3)
Bankruptcy (98)
Best Places to Work (2893)
Biosimilars (11)
Biotechnology (21)
Bladder cancer (10)
Brain cancer (7)
Breast cancer (48)
Cancer (470)
Cardiovascular disease (24)
Career advice (460)
Career pathing (4)
CAR-T (35)
Cell therapy (110)
Cervical cancer (2)
Clinical research (16147)
Collaboration (180)
Compensation (182)
Complete response letters (2)
COVID-19 (309)
CRISPR (9)
C-suite (115)
Cystic fibrosis (16)
Data (544)
Depression (7)
Diabetes (43)
Diagnostics (2059)
Digital health (3)
Diversity, equity & inclusion (14)
Drug discovery (15)
Drug pricing (6)
Drug shortages (1)
Duchenne muscular dystrophy (18)
Earnings (41064)
Editorial (2)
Employer branding (8)
Employer resources (42)
Events (38322)
Executive appointments (327)
FDA (4005)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (3)
Funding (195)
Gene editing (17)
Generative AI (2)
Gene therapy (54)
GLP-1 (112)
Government (416)
Guidances (51)
Healthcare (5084)
Huntington's disease (1)
IgA nephropathy (4)
Immunology and inflammation (14)
Indications (6)
Infectious disease (326)
Inflammatory bowel disease (25)
Inflation Reduction Act (2)
Influenza (3)
Intellectual property (16)
Interviews (66)
IPO (7844)
IRA (3)
Job creations (1124)
Job search strategy (411)
Kidney cancer (7)
Labor market (5)
Layoffs (102)
Leadership (6)
Legal (2373)
Liver cancer (18)
Lung cancer (54)
Lymphoma (32)
Management (15)
Manufacturing (53)
MASH (29)
Medical device (3884)
Medtech (3885)
Mergers & acquisitions (7466)
Metabolic disorders (126)
Multiple sclerosis (8)
NASH (6)
Neurodegenerative disease (11)
Neuropsychiatric disorders (1)
Neuroscience (348)
NextGen: Class of 2025 (1712)
Non-profit (753)
Now hiring (3)
Obesity (54)
Opinion (34)
Ovarian cancer (17)
Pain (14)
Pancreatic cancer (14)
Parkinson's disease (28)
Partnered (4)
Patents (24)
Patient recruitment (33)
Peanut (7)
People (24825)
Pharmaceutical (5)
Pharmacy benefit managers (2)
Phase I (4826)
Phase II (7004)
Phase III (5595)
Pipeline (621)
Policy (10)
Postmarket research (626)
Preclinical (1887)
Press Release (66)
Prostate cancer (28)
Psychedelics (3)
Radiopharmaceuticals (105)
Rare diseases (70)
Real estate (1881)
Recruiting (12)
Regulatory (5165)
Reports (14)
Research institute (325)
Resumes & cover letters (78)
Rett syndrome (4)
Schizophrenia (22)
Series A (28)
Series B (25)
Sickle cell disease (7)
Special edition (1)
Spinal muscular atrophy (28)
Sponsored (5)
Startups (1027)
Stomach cancer (1)
Supply chain (10)
Tariffs (5)
Vaccines (40)
Venture capitalists (3)
Weight loss (22)
Women's health (1)
Worklife (2)
Date
Today (105)
Last 7 days (310)
Last 30 days (840)
Last 365 days (9961)
2025 (3451)
2024 (11103)
2023 (13254)
2022 (18738)
2021 (19782)
2020 (18356)
2019 (13398)
2018 (10355)
2017 (10110)
2016 (9280)
2015 (12254)
2014 (9682)
2013 (7777)
2012 (8400)
2011 (8872)
2010 (8690)
Location
Africa (187)
Alabama (13)
Alaska (2)
Arizona (59)
Arkansas (1)
Asia (11492)
Australia (1636)
California (2066)
Canada (732)
China (73)
Colorado (85)
Connecticut (98)
Delaware (31)
Europe (24743)
Florida (297)
Georgia (34)
Idaho (24)
Illinois (117)
India (7)
Indiana (64)
Iowa (2)
Japan (76)
Kansas (24)
Kentucky (11)
Louisiana (5)
Maine (41)
Maryland (233)
Massachusetts (1648)
Michigan (87)
Minnesota (143)
Mississippi (1)
Missouri (24)
Montana (16)
Nebraska (12)
Nevada (25)
New Hampshire (16)
New Jersey (590)
New Mexico (6)
New York (491)
North Carolina (339)
North Dakota (3)
Northern California (999)
Ohio (60)
Oklahoma (6)
Oregon (4)
Pennsylvania (361)
Puerto Rico (1)
Rhode Island (13)
South America (280)
South Carolina (7)
Southern California (738)
Tennessee (41)
Texas (241)
United States (7427)
Utah (66)
Virginia (48)
Washington D.C. (11)
Washington State (181)
West Virginia (2)
Wisconsin (26)
227,369 Results for "parker hannifin corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Parker Institute Appoints Renowned Cancer Immunologist Dr. Ira Mellman as President of Research
April 10, 2025
·
4 min read
Press Releases
Karen Knudsen, MBA PhD, Appointed Chief Executive Officer of the Parker Institute for Cancer Immunotherapy
April 1, 2025
·
7 min read
Biotech Bay
The Parker Institute for Cancer Immunotherapy Awards More Than $1 Million to Four Early Career Investigators
The Parker Institute for Cancer Immunotherapy, a collaborative consortium of the world’s leading immuno-oncology experts, named its 2024 class of Early Career Researcher awardees who are poised to redefine what is possible in cancer research.
June 27, 2024
·
6 min read
Business
BostonGene and the Parker Institute for Cancer Immunotherapy Collaborate to Generate Comprehensive Longitudinal Multi-Omic Data for Predicting Immunotherapy Outcomes
BostonGene and the Parker Institute for Cancer Immunotherapy (PICI), a network of the largest concentration of immuno-oncology (IO) expertise in the world, announced today the launch of a collaboration aimed at uncovering molecular mechanisms underlying IO treatment response and treatment-related toxicity in advanced cancer patients and discovering actionable blood-based biomarkers.
April 30, 2024
·
5 min read
Press Releases
Savara Appoints Braden Parker as Chief Commercial Officer, Effective Immediately
September 25, 2024
·
5 min read
Business
Allogene Therapeutics Appoints Geoffrey Parker as Chief Financial Officer
Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for cancer, has appointed Geoffrey Parker as Executive Vice President, Chief Financial Officer.
October 16, 2023
·
4 min read
Press Releases
Nomic® and Parker Institute for Cancer Immunotherapy (PICI) Launch Large-Scale Protein Profiling to Investigate Immunotherapy Responses in RADIOHEAD Study
September 25, 2024
·
5 min read
Business
Codexis Announces Appointment of H. Stewart Parker to Board of Directors
Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the appointment of H. Stewart Parker to its Board of Directors.
December 20, 2022
·
3 min read
Business
Developing Next-Gen Scientific Leaders: The Parker Institute for Cancer Immunotherapy Awards up to $2.9 Million to Eight Early Career Investigators
Powered by a commitment to accelerating bold, emerging science, the Parker Institute for Cancer Immunotherapy continues to invest in the next generation of scientific leaders and their ambitious ideas for curative cancer treatments.
June 27, 2023
·
6 min read
Pharm Country
Parker Health Names Dr. Philip McDonald as Its First Chief Medical Officer
Parker Health, a biotechnology company, names Philip McDonald, MD as the company’s first Chief Medical Officer.
January 5, 2023
·
2 min read
1 of 22,737
Next
